(RTTNews) - Prometheus Biosciences Inc. (RXDX) said that it has priced an underwritten offering of about 4.55 million shares of its common stock at a price to the public of $110 per share. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results